Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Kiniksa Pharmaceuticals International Plc (NQ: KNSA ) 26.05 -0.07 (-0.27%) Streaming Delayed Price Updated: 1:15 PM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Kiniksa Pharmaceuticals International Plc < Previous 1 2 3 Next > 7 Thrilling Biotech Stocks for Aggressive Investors to Buy April 05, 2023 Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. Via InvestorPlace 7 Small-Cap Stocks to Buy for Explosive Growth Potential March 30, 2023 Although small-cap stocks to buy presents higher risks than the large caps, the segment also enjoys critical advantages. Via InvestorPlace 7 Dirt-Cheap Stocks Sitting in the Sweet Spot March 23, 2023 These cheap stocks don’t just attract on the ticker tape but rather feature compelling fundamentals and analysts’ upside projections. Via InvestorPlace The Top 7 Growth Stocks in Biotech March 03, 2023 The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. Via InvestorPlace 5 Value Stocks In The Healthcare Sector January 09, 2023 Via Benzinga Kiniksa Inks Global License Agreement With Roche For Vixarelimab August 03, 2022 Via Benzinga Recap: Kiniksa Pharmaceuticals Q1 Earnings May 03, 2022 Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Earnings Scheduled For February 22, 2022 February 22, 2022 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... Via Benzinga Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday November 02, 2022 Gainers Via Benzinga Gartner, Sony, Uber And Other Big Gainers From Tuesday November 02, 2022 U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session November 01, 2022 Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. Via Benzinga Recap: Kiniksa Pharmaceuticals Q3 Earnings November 01, 2022 Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Kiniksa... Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session October 24, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Kiniksa Pharmaceuticals: Q2 Earnings Insights August 03, 2022 Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q2 earnings results on Wednesday, August 3, 2022. Here's what investors need to know about the announcement. Via Benzinga Week In Review: Huadong Pharma Enters $662 Million Deal For Two Kiniksa Anti-Inflammatory Drugs February 26, 2022 Huadong Pharma announced a $662 million agreement to develop two Kiniksa Pharma anti-inflammatory drug candidates in southeast Asia (ex-Japan). Huadong will pay $22 million and be responsible for up to... Via Talk Markets Kiniksa Pharma, Huadong Medicine Ink Licensing Pact For Arcalyst, Mavrilimumab February 22, 2022 Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) and Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd., a subsidiary of Huadong Medicine Co., Ltd., have announced a strategic... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday June 01, 2022 On Wednesday, 73 stocks hit new 52-week lows. Via Benzinga Kiniksa Pharmaceuticals: Q4 Earnings Insights February 22, 2022 Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM. Here's what investors need to know about the... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 11, 2022 Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is... Via Benzinga 10 Biggest Price Target Changes For Wednesday December 29, 2021 Tigress Financial lifted the price target on McDonald's Corporation (NYSE: Via Benzinga Why Kiniksa Pharmaceuticals Stock Is Falling Today December 28, 2021 Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) is trading lower Tuesday morning after the company announced the Phase 3 trial of mavrilimumab in COVID-19-related ARDS did not... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 28, 2021 Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market session. The company's market cap stands at $47.1... Via Benzinga 71 Biggest Movers From Yesterday November 03, 2021 Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales... Via Benzinga Mid-Afternoon Market Update: Dow Rises Around 150 Points; Semler Scientific Shares Slide November 02, 2021 Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,063.98 while the NASDAQ rose 0.03% to 15,600.42. The S&P also rose, gaining 0.28% to 4,626.45. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session November 02, 2021 Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%... Via Benzinga 64 Biggest Movers From Yesterday November 02, 2021 Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... Via Benzinga Earnings Scheduled For November 1, 2021 November 01, 2021 Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:... Via Benzinga The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout October 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.